Clinical trials
Phase 2 Sarcoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 3 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 25 |
| Recruiting | 18 |
| Not yet recruiting | 8 |
| Completed | 8 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 11 |
| Fudan University | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 6 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 4 |
| Tianjin Medical University Cancer Institute and Hospital | 4 |
| Ruijin Hospital | 3 |
| Bayer | 2 |
| Peking University People's Hospital | 2 |
| Shanghai 6th People's Hospital | 2 |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 65 |
| Osteosarcoma | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Liposarcoma | 3 |
| Melanoma | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Desmoplastic Small Round Cell Tumor | 2 |
| Fibrosarcoma | 2 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.